World Renal Biomarkers Market - Opportunities and Forecasts, 2014 - 2022 - iCrowdNewswire

RSS Newsfeeds

See all RSS Newsfeeds

Jul 28, 2017 9:15 AM ET

World Renal Biomarkers Market – Opportunities and Forecasts, 2014 – 2022

iCrowdNewswire - Jul 28, 2017

The “World Renal Biomarkers Market – Opportunities and Forecasts, 2014 – 2022” report has been added to Research and Markets’ offering.

Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.

There is an impending need for specific and sensitive biomarkers that can identify kidney diseases at the earliest. The early identification helps to take timely preventive steps, before the damage becomes irreversible.

The major factors fuelling the global renal biomarkers market are; increased incidence of kidney diseases, large geriatric population and increasing prevalence of multiple co-morbidities.

The market would also gain prominence due to rising incidences of chronic diseases such as diabetes, obesity and hypertension, as these diseases are often associated with the gradual loss of kidney function.

The companies profiled in the report include, Abbott Diagnostics, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Siemens Healthcare Diagnostics Inc., Thermo Fisher Scientific Inc., Astute Medical Inc., Alere Inc., bioM?rieux SA and Randox Laboratories Ltd.

The global renal biomarkers market is segmented below:

Global Renal Biomarkers Market – By Marker Type

– Creatinine
– Blood urea nitrogen (BUN)
– Cystatin C
– Neutrophil gelatinase-associated lipocalin (NGAL)


– N-Acetyl-?-D-Glucosaminidase (NAG)
– Kidney Injury Molecule 1 (Kim1)
– TIMP-2 (TIMP metallopeptidase inhibitor 2)
– Liver-Type Fatty Acid-Binding Protein (L-FABP)
– Interleukin-18 (IL-18)
– Clusterin

Global Renal Biomarkers Market – By Assay Platform Type

– Enzyme Linked Immunosorbent Assay (ELISA)
– Enzymatic Assay
– Turbidimetric Immunoassay
– Particle-Enhanced Turbidimetric Immunoassay (PETIA)


– Chemiluminescent Immunoassay (CLIA)
– Fluorescence Immunoassay

Global Renal Biomarkers Market – By Application

– Diagnosis and disease progression monitoring
– Research

Global Renal Biomarkers Market – By Geography

– North America
– Europe
– Asia-Pacific

For more information about this report visit

Contact Information:

Research and Markets,
Laura Wood,
Senior Manager.
[email protected]
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Related Topics: Biomarkers (

Via iCrowdNewswire
View Related News >